Kestra Medical Technologies, Ltd. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Kestra Medical Technologies, Ltd. stock issued during period, value, new issues for the quarter ending 2026-01-31 was $148.29M.
- Kestra Medical Technologies, Ltd. stock issued during period, value, new issues for the quarter ending 2024-07-31 was $17.10M.
- Kestra Medical Technologies, Ltd. stock issued during period, value, new issues for fiscal 2026 was $148.29M, a 29.52% decline from fiscal 2025.
- Kestra Medical Technologies, Ltd. stock issued during period, value, new issues for fiscal 2025 was $210.39M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-04-30 | $148.29M 10-K · filed 2026-07-14 | |
| 2026-01-31 | $148.29M 10-Q · filed 2026-03-17 | |
| 2025-04-30 | $210.39M 10-K · filed 2026-07-14 | |
| 2024-07-31 | $17.10M 10-Q · filed 2025-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |